Principles of surgical radicality in the treatment of gastric cancer

Surgical Oncology Clinics of North America

Volumn 10, Issue 4, 2001, Pages 833-854

  Bozzetti, F ^a  

^a Residenza Querce Milano Due   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; LAPAROTOMY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; METASTASIS; MULTICENTER STUDY; REVIEW; SPLENECTOMY; STOMACH CANCER; SURGICAL TECHNIQUE;

EID: 0035170056     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1055-3207(18)30035-8     Document Type: Review

References (135)

1. Surgical results in patients with gastric carcinoma involving the mesocolon
2. A simple classification of lymph node level in gastric carcinoma
3. Laparoscopy-assisted Billroth I gastrectomy compared with conventional open gastrectomy
4. Predictive factors for metachronous recurrence of early gastric cancer after endoscopic treatment
5. Laparoscopically assisted total or distal gastrectomy with lymph node dissection for early gastric cancer
6. Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer
7. Preoperative assessment of lymph node metastases in patients with gastric cancer: Evaluation of the Maruyama computer program
8. Extended lymph-node dissection for gastric cancer
9. Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients
10. Rationale for extended lymphadenectomy in gastrectomy for carcinoma
11. Prognostic effects of lymph node micrometastases in patients undergoing curative gastrectomy for cancer
12. Adequacy of margins of resection in gastrectomy for cancer
13. Early gastric cancer: Unrecognized indicator of multiple malignancies
14. How long is a 6-cm margin of resection in the stomach?
15. Subtotal versus total gastrectomy for gastric cancer: Five-year survival in a multicenter randomized Italian trial
16. The Italian Gastrointestinal Tumor Study Group: Surgical morbidity and mortality rates in a multicenter Italian randomized trial
17. Comparison of nutritional status after total or subtotal gastrectomy
18. Early and late results of extended surgery for cancer of the stomach
19. Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma
20. Lymph node staging standards in gastric cancer
21. Micrometastasis in lymph node and microinvasion of the muscularis propria in primary lesions of submucosal gastric cancer
22. Micrometastasis in lymph nodes of mucosal gastric cancer
23. Preoperative staging of gastric carcinoma using endosonography
24. II Trattamento del carcinoma gastrico. Collana Monografica
25. A model for gastric cancer epidemiology
26. Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial
27. Nodal abdominal spread in adenocarcinoma of the cardia: Results of a multicenter prospective study
28. Experience of endoscopic ultrasound in staging adenocarcinoma of the cardia
29. Prognostic significance of lymph node dissection in gastric cancer
30. Morbidity and mortality after D2 gastrectomy for gastric cancer: Results of the Italian Gastric Cancer Study Group. Prospective multicenter surgical study
31. Controlled trials and the R-1/R-2 controversy in the management of gastric carcinoma
32. Controlled trials and the R1/R2 controversy in the management of gastric carcinoma
33. Role of endoscopic ultrasonography in gastric carcinoma
34. Investigation on the lymphatic spread of gastric carcinoma
35. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer
36. Clinical evaluation of lymph node metastasis in gastric cancer defined by the fifth edition of the TNM classification in comparison with the Japanese system
37. Efficacy of helical CT in T-staging of gastric cancer
38. Analysis of early gastric cancer cases collected from major hospitals and institutes in Japan
39. Limited surgery for early gastric cancer in cardia
40. Phase II study of limited surgery for early gastric cancer: Segmental gastric resection
41. Total gastrectomy with dissection of lymph nodes along the splenic artery: A pancreas-preserving model
42. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study
43. Early gastric cancer
44. Endosonography for preoperative locoregional staging of esophageal and gastric cancer
45. Evaluation of the Maruyama computer program accuracy for preoperative estimation of lymph node metastases from gastric cancer
46. Non-ominous micrometastases of gastric cancer
47. Results of surgery in patients with gastric cancer extending to the adjacent organs
48. Early detection of gastric cancer
49. Prognostic significance of immunohistochemical metastases in node negative gastric cancer patients
50. Superiority of a new UICC-TNM staging system for gastric carcinoma
51. Bacterial N-nitrosation and gastric carcinogenesis in humans
52. CT of gastric carcinoma: Preliminary results with a new scanning technique
53. Adenocarcinoma of the gastroesophageal junction
54. Comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage based on their location in patients with gastric cancer
55. Immunohistochemical evaluation of lymph node micrometastases from gastric carcinomas
56. Risk factors of lymph node metastases and recurrence from intramucosal gastric cancer
57. The general rules for the gastric cancer study in surgery and pathology. Part I
58. Computer analysis in making preoperative decisions: A rational approach to lymph node dissection in gastric cancer patients
59. Evaluation of the New International Union against cancer TNM staging for gastric carcinoma
60. Correlation between microsatellite instability and metachronous disease recurrence after endoscopic mucosal resection in patients with early stage gastric carcinoma
61. Incidence and prognosis of N4 node involvement in gastric cancer
62. The role of the sentinel lymph node in gastrointestinal cancer
63. Surgical treatment of early gastric cancer
64. Indications for pylorus preserving gastrectomy for early gastric cancer located in the middle third of the stomach
65. The number of metastatic lymph nodes: A promising prognostic determinant for gastric carcinoma in the latest edition of the TNM classification
66. Prognostic significance of combined splenectomy or pancreaticosplenectomy in total and proximal gastrectomy for gastric cancer
67. Cause of late postoperative death in patients with early gastric cancer with special reference to recurrence and the incidence of metachronous primary cancer in other organs
68. Clinical and pathologic evaluation of patients with recurrence of gastric cancer more than five years postoperatively
69. Results of resection of gastric cancer extending to adjacent organs
70. Long-term survival in Japanese patients with far advanced carcinoma of the stomach
71. Study on operative procedure from the point of postoperative survival rate and recurrence in gastric cancer
72. Early mucosal gastric cancer with extra-perigastric (n2) lymph node metastasis
73. Evaluation of gastric biopsies for neoplasia: Differences between Japanese and Western pathologists
74. Early gastric cancer
75. Splenectomy does not correlate with length of survival in patients undergoing curative total gastrectomy for gastric carcinoma
76. Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrence
77. Preoperative endoscopic ultrasonography in patients with gastric cancer
78. Lymph node metastases of gastric cancer
79. Progess in gastric cancer surgery in Japan and its limits of radicality
80. Can sentinel node biopsy indicate rational extent of lympadenectomy in gastric cancer surgery?
81. Endoscopic ultrasonography for preoperative staging of gastric carcinoma
82. Carcinoma of thoracic esophagus and cardia
83. Gastric tumors: Radiologic pathologic correlation and accuracy of T staging with dynamic CT
84. Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction
85. Prognostic differences of adenocarcinoma arising from the cardia and the upper third of the stomach
86. Occult lymph node metastasis in gastric cancer with submucosal invasion
87. Combined resection
88. Detection of gastric cancer micrometastases in lymph nodes by amplification of keratin 19 mRNA with reverse transcriptasepolymerase chain reaction
89. Radical surgery for gastric cancer: A review of the Japanese experience
90. Curative laparoscopic surgery for early gastric cancer: Five years experience
91. Segmental gastrectomy for early cancer in the midstomach
92. Principles of surgical treatment
93. Adenocarcinoma in the upper third part of the stomach
94. Significance of dissecting lateroaortic lymph node (around the renal vein) in cardiac cancer
95. Recent advances in surgical treatment have improved the survival of patients with gastric carcinoma
96. An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas
97. Extensive versus limited lymph node dissection for gastric cancer: A comparative study of 320 patients
98. Histologically positive esophageal margin in the surgical treatment of gastric cancer
99. Carcinoma of the stomach with special reference to total gastrectomy
100. An improved method for the analysis of total N-nitroso compounds in gastric juice
101. Gastric juice N-nitrosamines in health and gastroduodenal disease
102. A prospective randomized trial comparing R 1 subtotal gastrectomy with R3 total gastrectomy for antral cancer
103. Lymphadenectomy for gastric cancer in clinical trials: Update
104. Early gastric cancer: Endoscopic diagnosis of depth of invasion
105. Radical surgery in gastric cancer
106. Significance of total gastrectomy combined with resection of tail of pancreas and spleen
107. Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists
108. Total gastrectomy
109. Assessment and resection of carcinoma at the gastroesophageal junction
110. Preliminary report on local resection with lymphadenectomy for early gastric cancer
111. Extended gastrectomy for gastric cancer
112. Indication for an outcome of laparoscopy-assisted Billroth I gastrectomy
113. Adenocarcinoma of the stomach: A multivariate analysis of clinical, pathologic and treatment factors
114. Prognostic relevance of systematic lymph node dissection in gastric carcinoma
115. Relevant prognostic factors in gastric cancer. Ten-year results of the German Gastric Cancer Study
116. 1, lymph node metastases
117. A statistical evaluation of advancement in gastric cancer surgery with special reference to the significance of lymphadenectomy for cure
118. Critical evaluation of prophylactic splenectomy in total gastrectomy for stomach cancer
119. Difference between carcinoma of the lower esophagus and the cardia
120. Gastric cancer (postoperative long-term survivals after extended radical operation)
121. Significance of combined resection of adjacent organs for advanced cancer of the stomach
122. Examination of combined resection of the tail of the pancreas and spleen in advanced cancer of upper and midstomach
123. Proximal gastrectomy and jejunal pouch interposition for the treatment of early cancer in the upper third of the stomach: Surgical techniques and evaluation of postoperative function
124. TNM classification
125. Lymph node counts in the upper abdomen: Anatomical basis for lymphadenectomy in gastric cancer
126. Cancer of the stomach. A patient care study by the American College of Surgeons
127. Evaluation of missing diagnosis of metastatic lymph nodes in gastric cancer
128. Transgastrostomal endoscopic surgery for early gastric carcinoma and submucosal tumor
129. Resection margin in patients with gastric cancer associated with oesophageal invasion: Clinicopathological study
130. Surgical treatment of advanced gastric cancer with metastasis in para-aortic lymph node
131. Pancreaticoduodenectomy in combination with right hemicolectomy for surgical treatment of advanced gastric carcinoma located in the lower half of the stomach
132. Lymph node metastasis and surgical management of gastric cancer invading the esophagus
133. Endoscopic treatment